The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection
Open accessAbstract
Secondary pneumococcal pneumonia is a serious complication during and shortly after influenza infection. We established a mouse model to study postinfluenza pneumococcal pneumonia and evaluated the role of IL-10 in host defense against Streptococcus pneumoniae after recovery from influenza infection. C57BL/6 mice were intranasally inoculated with 10 median tissue culture infective doses of influenza A (A/PR/8/34) or PBS (control) on day 0. By day 14 mice had regained their normal body weight and had cleared influenza virus from the lungs, as determined by real-time quantitative PCR. On day 14 after viral infection, mice received 104 CFU of S. pneumoniae (serotype 3) intranasally. Mice recovered from influenza infection were highly susceptible to subsequent pneumococcal pneumonia, as reflected by a 100% lethality on day 3 after bacterial infection, whereas control mice showed 17% lethality on day 3 and 83% lethality on day 6 after pneumococcal infection. Furthermore, 1000-fold higher bacterial counts at 48 h after infection with S. pneumoniae and, particularly, 50-fold higher pulmonary levels of IL-10 were observed in influenza-recovered mice than in control mice. Treatment with an anti-IL-10 mAb 1 h before bacterial inoculation resulted in reduced bacterial outgrowth and markedly reduced lethality during secondary bacterial pneumonia compared with those in IgG1 control mice. In conclusion, mild self-limiting influenza A infection renders normal immunocompetent mice highly susceptible to pneumococcal pneumonia. This increased susceptibility to secondary bacterial pneumonia is at least in part caused by excessive IL-10 production and reduced neutrophil function in the lungs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Yearbook of Intensive Care and Emergency Medicine 2002
(2002) · Springer eBooks · doi:10.1007/978-3-642-56011-8 · Cited by 876
The impact of influenza epidemics on mortality: introducing a severity index.
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.12.1944 · Cited by 587
STUDIES ON INFLUENZA IN THE PANDEMIC OF 1957-1958. II. PULMONARY COMPLICATIONS OF INFLUENZA*†
Louria, D. B., Blumenfeld, H. L., Ellis, J. T., Kilbourne, E. D., & Rogers, D. E. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103791 · Cited by 479
Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR
van Elden, L. J. R., Nijhuis, M., Schipper, P., Schuurman, R., & van Loon, A. M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.196-200.2001 · Cited by 456
Self-citationMcCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423
Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia
Greenberger, M. J., Strieter, R. M., Kunkel, S. L., Danforth, J. M., Goodman, R. E., & Standiford, T. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.722 · Cited by 325
Alveolar Macrophages Have a Protective Antiinflammatory Role during Murine Pneumococcal Pneumonia
Knapp, S., Leemans, J. C., Florquin, S., Branger, J., Maris, N. A., Pater, J., van Rooijen, N., & van der Poll, T. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-698oc · Cited by 302
Self-citationMarchant, A., Bruyns, C., Vandenabeele, P., Ducarme, M., Gérard, C., Delvaux, A., De Groote, D., Abramowicz, D., Velu, T., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240524 · Cited by 294
Self-citationIL-10 Is a Major Mediator of Sepsis-Induced Impairment in Lung Antibacterial Host Defense
Steinhauser, M. L., Hogaboam, C. M., Kunkel, S. L., Lukacs, N. W., Strieter, R. M., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.392 · Cited by 289
Endogenous IL-10 protects mice from death during septic peritonitis
van der Poll, T., Marchant, A., Buurman, W. A., Berman, L., Keogh, C. V., Lazarus, D. D., Nguyen, L., Goldman, M., Moldawer, L. L., & Lowry, S. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5397 · Cited by 285
Self-citationO'Brien, K. L., Walters, M. I., Sellman, J., Quinlisk, P., Regnery, H., Schwartz, B., & Dowell, S. F. (2000) · Clinical Infectious Diseases · doi:10.1086/313772 · Cited by 279
Role of Staphylococcus protease in the development of influenza pneumonia
Tashiro, M., Ciborowski, P., Klenk, H.-D., Pulverer, G., & Rott, R. (1987) · Nature · doi:10.1038/325536a0 · Cited by 273
Interieukin-10 Impairs Host Defense in Murine Pneumococcal Pneumonia
van der Poll, T., Marchant, A., Keogh, C. V., Goldman, M., & Lowry, S. F. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.994 · Cited by 255
Self-citationPlotkowski, M.-C., Puchelle, E., Beck, G., Jacquot, J., & Hannoun, C. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1040 · Cited by 231
Pajkrt, D., Camoglio, L., Tiel-van Buul, M. C., de Bruin, K., Cutler, D. L., Affrime, M. B., Rikken, G., van der Poll, T., ten Cate, J. W., & van Deventer, S. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3971 · Cited by 196
Self-citationKozak, W., Poli, V., Soszyński, D., Conn, C. A., Leon, L. R., & Kluger, M. J. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.272.2.r621 · Cited by 126
Rijneveld, A. W., Florquin, S., Branger, J., Speelman, P., van Deventer, S. J. H., & van der Poll, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5240 · Cited by 126
Self-citationHost innate defenses in the lung: the role of cytokines
Strieter, R. M., Belperio, J. A., & Keane, M. P. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200306000-00002 · Cited by 126
Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice
LeVine, A. M., Koeningsknecht, V., & Stark, J. M. (2001) · Journal of Virological Methods · doi:10.1016/s0166-0934(01)00287-7 · Cited by 120
IL-18 Improves the Early Antimicrobial Host Response to Pneumococcal Pneumonia
Lauw, F. N., Branger, J., Florquin, S., Speelman, P., van Deventer, S. J. H., Akira, S., & van der Poll, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.372 · Cited by 119
Self-citationMicrobiological and Inflammatory Factors Associated with the Development of Pneumococcal Pneumonia
Dallaire, F., Ouellet, N., Bergeron, Y., Turmel, V., Gauthier, M., Simard, M., & Bergeron, M. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/322021 · Cited by 115
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114
PULMONARY COMPLICATIONS OF INFLUENZA
Scadding, J. G. (1952) · The Lancet · doi:10.1016/s0140-6736(52)92362-3 · Cited by 107
Abramson, J. S., Mills, E. L., Giebink, G. S., & Quie, P. G. (1982) · Infection and Immunity · doi:10.1128/iai.35.1.350-355.1982 · Cited by 96
Wagner, R. D., Maroushek, N. M., Brown, J. F., & Czuprynski, C. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2345-2353.1994 · Cited by 84
Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice
Zhang, W. J., Sarawar, S. R., Nguyen, P., Daly, K. R., Rehg, J. E., Doherty, P. C., Woodland, D. L., & Blackman, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5049 · Cited by 69
Effects of Infection with Influenza Virus on the Function of Polymorphonuclear Leukocytes
Martin, R. R., Couch, R. B., Greenberg, S. B., Cate, T. R., & Warr, G. A. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/144.3.279 · Cited by 50
Characterization of the effect of influenza virus on polymorphonuclear leukocyte membrane responses
Abramson, J. S., Parce, J. W., Lewis, J., Lyles, D. S., Mills, E. L., Nelson, R., & Bass, D. (1984) · Blood · doi:10.1182/blood.v64.1.131.131 · Cited by 48
Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity
Jovasevic, V. M., Gorelik, L., Bluestone, J. A., & MOKYR, M. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1449 · Cited by 46
Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci
Jones, W. T., Menna, J. H., & Wennerstrom, D. E. (1983) · Infection and Immunity · doi:10.1128/iai.41.2.618-623.1983 · Cited by 32
Tracheal function during influenza infections
NUGENT, K. M., & Pesanti, E. L. (1983) · Infection and Immunity · doi:10.1128/iai.42.3.1102-1108.1983 · Cited by 32
Mechanisms of bacterial superinfections in viral pneumonias.
Jakab, G. J. (1985) · PubMed · Cited by 29
Jones, W. T., & Menna, J. H. (1982) · Infection and Immunity · doi:10.1128/iai.38.2.791-794.1982 · Cited by 16
Regulatory Role of Alveolar Macrophages and Cytokines in Pulmonary Host Defense
Schultz, M. J., Knapp, S., & van der Poll, T. (2002) · Springer eBooks · doi:10.1007/978-1-4757-5551-0_6 · Cited by 6
Cited by
Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 747
The co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers, J. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3231 · Cited by 722
Metadata
- Authors
- van der Sluijs, K. F., van Elden, L. J. R., Nijhuis, M., Schuurman, R., Pater, J. M., Florquin, S., Goldman, M., Jansen, H. M., Lutter, R., & van der Poll, T.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06
- Volume
- 172
- Issue
- 12
- Pages
- 7603-7609
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2116498531
- Cited by
- 334
- References
- 37
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.